The National Institutes of Health (NIH) intends to award a sole-source Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Bio-Rad Laboratories Inc. for the procurement of quality control (QC) materials essential for use with Roche COBAS PRO Solutions analyzers. The required QC materials, which include various levels of tumor markers and immunoassays, are critical for verifying the accuracy and reliability of analyzer results, ensuring that the instruments function correctly and produce precise test outcomes. This procurement is conducted under FAR Part 13, allowing for a single-source solicitation due to the unique specifications of the Bio-Rad products, with a performance period from May 28, 2025, to September 30, 2025. Interested parties who believe they can meet these requirements must submit a capability statement to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by May 27, 2024, at 6:30 AM EST.